1770 NEOADJUVANT SHORT-TERM INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN COMPARED TO STANDARD SCHEDULE FOR LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER. A RANDOMIZED PHASE II STUDY

Randomized Phase Ii ◽

429 NEOADJUVANT INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN VERSUS STANDARD SCHEDULE FOR NON MUSCLE INVASIVE BLADDER CANCER. RANDOMIZED PHASE II STUDY

European Urology Supplements ◽

10.1016/s1569-9056(11)60422-3 ◽

2011 ◽

Vol 10 (2) ◽

pp. 148

Author(s):

L. Rocchini ◽

F. Pellucchi ◽

B. Ibrahim ◽

C. Maccagnano ◽

M. Freschi ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Phase Ii ◽

Phase Ii Study ◽

Invasive Bladder Cancer ◽

Randomized Phase Ii ◽

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer

BJU International ◽

10.1111/bju.15038 ◽

2020 ◽

Vol 125 (6) ◽

pp. 817-826 ◽

Cited By ~ 4

Author(s):

A. Hugh Mostafid ◽

Nuria Porta ◽

Joanne Cresswell ◽

Thomas R.L. Griffiths ◽

John D. Kelly ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Surgical Management ◽

Phase Ii ◽

Low Risk ◽

Feasibility Trial ◽

Invasive Bladder Cancer ◽

A randomized phase II study of a novel antigen-presenting cell-targeted hCG-β vaccine (the CDX-1307 regimen) in muscle-invasive bladder cancer.

10.1200/jco.2010.28.15_suppl.tps228 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS228-TPS228

Author(s):

D. A. Bradley ◽

M. Morse ◽

T. Keler ◽

J. A. Green ◽

T. A. Davis ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Invasive Bladder Cancer ◽

Antigen Presenting Cell ◽

Randomized Phase Ii ◽

Muscle Invasive ◽

Antigen Presenting

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer

BJU International ◽

10.1111/bju.15214 ◽

2020 ◽

Vol 126 (6) ◽

pp. 663-663

Author(s):

Francesco Montorsi ◽

Marco Moschini ◽

Andrea Necchi

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Surgical Management ◽

Phase Ii ◽

Low Risk ◽

Feasibility Trial ◽

Invasive Bladder Cancer ◽

Review of SWOG S1314: Lessons from a Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer

Bladder Cancer ◽

10.3233/blc-190266 ◽

2020 ◽

Vol 6 (2) ◽

pp. 123-129 ◽

Cited By ~ 2

Author(s):

Peter Boxley ◽

Melissa Plets ◽

Thomas W. Flaig

Keyword(s):

Bladder Cancer ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Invasive Bladder Cancer ◽

Randomized Phase Ii ◽

Long-term experience with early single Mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial

World Journal of Urology ◽

10.1007/s00345-011-0691-2 ◽

2011 ◽

Vol 29 (4) ◽

pp. 517-521 ◽

Cited By ~ 21

Author(s):

Cosimo De Nunzio ◽

Antonio Carbone ◽

Simone Albisinni ◽

Giorgio Alpi ◽

Andrea Cantiani ◽

...

Keyword(s):

Bladder Cancer ◽

Mitomycin C ◽

Randomised Trial ◽

Low Risk ◽

Invasive Bladder Cancer ◽

Single Centre ◽

Muscle Invasive ◽

Long Term Experience

Long-term results of a phase II study of synchronous chemo radiotherapy in muscle invasive bladder cancer

10.1200/jco.2004.22.14_suppl.4585 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4585-4585 ◽

Cited By ~ 1

Author(s):

S. A. Hussain ◽

D. D. Stocken ◽

D. R. Peake ◽

J. G. Glaholm ◽

A. Zarkar ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Long Term Results ◽

Invasive Bladder Cancer ◽

Long-term results of a phase II study of synchronous chemo radiotherapy in muscle invasive bladder cancer

10.1200/jco.2004.22.90140.4585 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4585-4585

Author(s):

S. A. Hussain ◽

D. D. Stocken ◽

D. R. Peake ◽

J. G. Glaholm ◽

A. Zarkar ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Long Term Results ◽

Invasive Bladder Cancer ◽

A randomized, prospective, phase II study to determine the efficacy of BCG given in combination with panvac versus BCG alone in adults with high grade non-muscle invasive bladder cancer who failed at least one induction course of BCG.

10.1200/jco.2014.32.15_suppl.tps4590 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS4590-TPS4590 ◽

Cited By ~ 2

Author(s):

Sam Joseph Brancato ◽

Lambros Stamatakis ◽

Andrea Borghese Apolo ◽

Sarah Fowler ◽

Jeffrey Schlom ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Invasive Bladder Cancer ◽

High Grade ◽

Prospective Phase ◽

A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).

10.1200/jco.2018.36.15_suppl.4506 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 4506-4506 ◽

Cited By ~ 37

Author(s):

Thomas Powles ◽

Alejo Rodriguez-Vida ◽

Ignacio Duran ◽

Simon J. Crabb ◽

Michiel Simon Van Der Heijden ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Invasive Bladder Cancer ◽

Safety And Efficacy ◽